Tag: BioTherapeutics
Posted in Capital
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement – Information Global Web
NEW YORK, June 19, 2024 /PRNewswire/ — SMITM CAPITAL MARKETS LTD, has declared a momentous commendation with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage primed US biopharmaceutical company. This commendation entails a top substance of USD 5 million, supplying MABT’s start efforts to conflict rabies, a currently untreatable and highly mortal viral disease.
…